» Articles » PMID: 4980842

Transplacental Passage of Fetal Red Cells in Abortion; Increased Incidence After Curettage and Effect of Oxytocic Drugs

Overview
Journal Br Med J
Specialty General Medicine
Date 1969 Oct 11
PMID 4980842
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In a study of early abortions (less than 16-week pregnancies) no significant increase in fetomaternal haemorrhage was found in patients having either threatened or incomplete abortions. A statistically significant increase in fetal cells in the maternal circulation, however, occurred after curettage. The administration of oxytocic drugs in conjunction with curettage in cases of incomplete abortion did not increase the incidence of transplacental passage of fetal erythrocytes when compared with curettage alone. Of the 81 patients curetted following abortion four had a feto-maternal haemorrhage of more than 0.2 ml. The largest amount of fetal blood found in the maternal circulation was 0.4 to 0.5 ml. Preliminary data evaluating the indirect Coombs test and enzyme-treated red cells in Rh-negative post-abortion cases suggest that this amount of blood is not a primary immunizing dose but a "booster" to preformed antibody.

Citing Articles

Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study.

Slootweg Y, Zwiers C, Koelewijn J, van der Schoot E, Oepkes D, van Kamp I BJOG. 2022; 129(10):1721-1730.

PMID: 35133072 PMC: 9543810. DOI: 10.1111/1471-0528.17118.


Is anti-D immunoglobulin unnecessary in the domiciliary treatment of miscarriages?.

Everett C BMJ. 1988; 297(6650):732-3.

PMID: 2852516 PMC: 1834107. DOI: 10.1136/bmj.297.6650.732.

References
1.
GELLEN J, Kovacs Z, SZONTAGH F, Boda D . Surgical termination of pregnancy as a cause of rhesus sensitization. Br Med J. 1965; 2(5476):1471-2. PMC: 1847038. DOI: 10.1136/bmj.2.5476.1471. View

2.
Woodrow J, Finn R . Transplacental haemorrhage. Br J Haematol. 1966; 12(3):297-309. DOI: 10.1111/j.1365-2141.1966.tb05636.x. View

3.
Bergstrom H, Nilsson L, Nilsson L, RYTTINGER L . Demonstration of Rh antigens in a 38-day-old fetus. Am J Obstet Gynecol. 1967; 99(1):130-3. DOI: 10.1016/s0002-9378(16)34502-1. View

4.
Zipursky A, ISRAELS L . The pathogenesis and prevention of Rh immunization. Can Med Assoc J. 1967; 97(21):1245-57. PMC: 1923510. View

5.
ROSENFIELD R . Immunologic suppression of primary Rh antibody formation. Transfusion. 1968; 8(3):125-6. DOI: 10.1111/j.1537-2995.1968.tb04889.x. View